2-Oxoamide inhibitors of cytosolic group IVA phospholipase A2 with reduced lipophilicity

被引：5
|
作者：
Antonopoulou, Georgia [1 ,4 ]
Magrioti, Victoria [1 ]
Kokotou, Maroula G. [1 ]
Nikolaou, Aikaterini [1 ]
Barbayianni, Efrosini [1 ]
Mouchlis, Varnavas D. [2 ,3 ]
Dennis, Edward A. [2 ,3 ]
Kokotos, George [1 ]
机构：
[1] Univ Athens, Dept Chem, Athens 15771, Greece
[2] Univ Calif San Diego, Sch Med, Dept Chem & Biochem, MC 0601, La Jolla, CA 92093 USA
[3] Univ Calif San Diego, Sch Med, Dept Pharmacol, MC 0601, La Jolla, CA 92093 USA
[4] Natl Hellen Res Fdn, Inst Biol Med Chem & Biotechnol, Athens, Greece
来源：
BIOORGANIC & MEDICINAL CHEMISTRY | 2016年 / 24卷 / 19期
关键词：
GIVA cPLA(2); Inhibitors; Lipophilicity; 2-Oxoamides; Phospholipase A(2); IN-VITRO; PYRROLIDINE INHIBITORS; METABOLIC STABILITY; BIOLOGICAL-ACTIVITY; AMINO-ACIDS; A(2)ALPHA; DISCOVERY; POTENT; SERIES; 1-INDOL-1-YL-PROPAN-2-ONES;
D O I：
10.1016/j.bmc.2016.07.057
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Cytosolic GIVA phospholipase A(2) (GIVA cPLA(2)) initiates the eicosanoid pathway of inflammation and thus inhibitors of this enzyme constitute novel potential agents for the treatment of inflammatory diseases. Traditionally, GIVA cPLA(2) inhibitors have suffered systemically from high lipophilicity. We have developed a variety of long chain 2-oxoamides as inhibitors of GIVA PLA(2). Among them, AX048 was found to produce a potent analgesic effect. We have now reduced the lipophilicity of AX048 by replacing the long aliphatic chain with a chain containing an ether linked aromatic ring with in vitro inhibitory activities similar to AX048. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码：4544 / 4554
页数：11
相关论文
共 50 条
  • [31] Regulation of Lipid Droplet Formation by Group IVA Phospholipase A2
    Balsinde, Jesus
    Guijas, Carlos
    Rodriguez, Juan
    Rubio, Julio
    Balboa, Maria
    FASEB JOURNAL, 2015, 29
  • [32] Reduced group IVA phospholipase A2 expression is associated with unfavorable outcome for patients with gastric cancer
    Xia Zhang
    Qiong Wu
    Lu Gan
    Guan-Zhen Yu
    Rui Wang
    Zi-Shu Wang
    Jie-Jun Wang
    Xi Wang
    Medical Oncology, 2013, 30
  • [33] Group IVA phospholipase A2 is necessary for the biogenesis of lipid droplets
    Gubern, Albert
    Casas, Javier
    Barcelo-Torns, Miquel
    Barneda, David
    de la Rosa, Xavier
    Masgrau, Roser
    Picatoste, Fernando
    Balsinde, Jesus
    Balboa, Maria A.
    Claro, Enrique
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (41) : 27369 - 27382
  • [34] Group IVA phospholipase A2 participates in the progression of hepatic fibrosis
    Ishihara, Keiichi
    Miyazaki, Akira
    Nabe, Takeshi
    Fushimi, Hideaki
    Iriyama, Nao
    Kanai, Shiho
    Sato, Takashi
    Uozumi, Naonori
    Shimizu, Takao
    Akiba, Satoshi
    FASEB JOURNAL, 2012, 26 (10): : 4111 - 4121
  • [35] Reduced group IVA phospholipase A2 expression is associated with unfavorable outcome for patients with gastric cancer
    Zhang, Xia
    Wu, Qiong
    Gan, Lu
    Yu, Guan-Zhen
    Wang, Rui
    Wang, Zi-Shu
    Wang, Jie-Jun
    Wang, Xi
    MEDICAL ONCOLOGY, 2013, 30 (01)
  • [36] The ABC's of group IV cytosolic phospholipase A2
    Lucas, KK
    Dennis, EA
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2004, 1636 (2-3): : 213 - 218
  • [37] Essential Ca2+-independent role of the Group IVA cytosolic phospholipase A2 C2 domain for interfacial activity
    Six, DA
    Dennis, EA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (26) : 23842 - 23850
  • [38] Inherited human group IVA cytosolic phospholipase A2 deficiency abolishes platelet, endothelial, and leucocyte eicosanoid generation
    Kirkby, Nicholas S.
    Reed, Daniel M.
    Edin, Matthew L.
    Rauzi, Francesca
    Mataragka, Stefania
    Vojnovic, Ivana
    Bishop-Bailey, David
    Milne, Ginger L.
    Longhurst, Hilary
    Zeldin, Darryl C.
    Mitchell, Jane A.
    Warner, Timothy D.
    FASEB JOURNAL, 2015, 29 (11): : 4568 - 4578
  • [39] Impact of group IVA cytosolic phospholipase A2 gene polymorphisms on phenotypic features of patients with familial adenomatous polyposis
    Junji Umeno
    Takayuki Matsumoto
    Motohiro Esaki
    Yoji Kukita
    Tomoko Tahira
    Ritsuko Yanaru-Fujisawa
    Shotaro Nakamura
    Hisatomi Arima
    Minako Hirahashi
    Kenshi Hayashi
    Mitsuo Iida
    International Journal of Colorectal Disease, 2010, 25 : 293 - 301
  • [40] Inhibitors of secretory phospholipase A2 group IIA
    Reid, RC
    CURRENT MEDICINAL CHEMISTRY, 2005, 12 (25) : 3011 - 3026
12345